Evidence map›Paper›PMID 41250537›Full record

Trial reportZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2025

[Efficacy and safety of inhaled salbutamol sulfate combined with beclomethasone dipropionate in children with bronchial asthma: a randomized controlled study].

Chong-Zhi Chen, Qian Yang

Abstract readRandomized Controlled TrialEnglish Abstract
In one paragraph

Trial report in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chong-Zhi ChenDepartment of Pediatrics, Hengshui Fourth People's Hospital, Hengshui, Hebei 053000, China.
Qian YangDepartment of Pediatrics, Hengshui Fourth People's Hospital, Hengshui, Hebei 053000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the efficacy and safety of inhaled salbutamol sulfate combined with beclomethasone dipropionate in the treatment of pediatric bronchial asthma.

methodsA total of 106 children with bronchial asthma treated from December 2022 to November 2023 were randomly assigned to a control group (

resultsCompared with the control group, the treatment group had shorter times to symptom relief and complete symptom resolution (

conclusionsInhaled salbutamol sulfate combined with beclomethasone dipropionate improves clinical efficacy, promotes T helper 1/T helper 2 immune balance, optimizes multiple hematologic indices, and demonstrates good safety in children with bronchial asthma.

Indexed as

AlbuterolAsthmaBeclomethasoneAdministration, InhalationAdolescentChildChild, PreschoolDrug Therapy, CombinationFemaleHumansInterferon-gammaInterleukin-4MaleAlbuterolBeclomethasoneInterferon-gammaInterleukin-4Beclomethasone dipropionateBronchial asthmaChildInterferon-γInterleukin-4Salbutamol sulfate

Identifiers

PMID41250537
PMCPMC12688180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.